DND and CAF ‘exempt’ from further spending cuts, says Blair after department was asked to find $900-million a year in savings
Feds looking to find $15.8-billion in savings through ‘Refocus Government Spending’ initiative as pressure mounts for Canada to boost defence spending.
House filibuster is putting money for military, dental care, and keeping the government lights on at risk
Treasury Board President Anita Anand says departments are ‘okay for the next three to four weeks’ if a vote on supplementary estimates is delayed by the House standoff.
The prescription for Canada’s health care future
Focus on embracing the rapid pace of scientific discovery, letting innovation drive policy, and fostering collaboration across the health-care system.
Senate aims to serve up pharmacare for Thanksgiving
The Senate Social Affairs, Science, and Technology Committee will have just four weeks to study the pharmacare legislation before its scheduled third reading vote on Oct. 10.
The NDP-backed pharmacare plan is a corporate handout as written
The real problem with this signature legislation of the NDP-Liberal agreement is that it will not bring medicines within Canada’s publicly funded health system.
Liberals’ fall priorities should centre on building support from NDP, key voting blocs: lobbyists, pollsters
With a current ‘hodgepodge’ of bills before Parliament, the Liberals may want to form a cohesive narrative through their fall legislative agenda, says Yaroslav Baran.
Patients know about pharmacare: let’s listen to them on Bill C-64
Patient groups’ involvement should be built into the program, not just a one-time pre-consultation.
Health care is more than treatment—it’s time to get serious about disease prevention
The big news in health care these days is national pharmacare. This is surely welcome news for those of us living with any chronic illness. National pharmacare offers a dream—perhaps unrealistically, given the cost—that one day Canada might have a universal program covering all drugs for all diseases. Yet despite this hope, the proposed framework […]
Next step in universal drug coverage should prioritize ‘essential medicines,’ says pharmacare expert
Focusing on a list of the most commonly prescribed clinically-important drugs could save billions of dollars, both directly in terms of drug budget, and indirectly in terms of improvements in health care, says Steve Morgan, a professor of health policy at the University of British Columbia.
Patient involvement in pharmacare is critical to its success
Pharmacare is the most innovative and important health policy legislation in decades. To get it right, the federal government must directly engage with patients. Their expertise is crucial to pharmacare’s success.
